ArticleAnnals of hematology2026

Successful use of ruxolitinib in steroid-refractory chronic GvHD affecting central nervous system: a case report.

Ewa Karakulska-Prystupiuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.